INFANRIX DTPa-IPV susp inj (n ser pré) 0.5 ml
7680006380035
Pharmacode 1108356
CH-638
J07CA02
08.08.
Active substances:
1 / 2
google
Details
- GTIN
- 7680006380035
- Pharmacode
- 1108356
- Product number
- 0063801
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U.I., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U.I., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U.I., aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, natrii chloridum corresp. natrium 1.8 mg, medium 199, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, formaldehydum, polysorbatum 80.
Articles (1)
Infanrix DTPa-IPV, Injektionssuspension
Injektionssuspension
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
toxoidum diphtheriae
|
- | Substance | Wirkstoff (Principe actif) |
|
toxoidum tetani
|
- | Substance | Wirkstoff (Principe actif) |
|
toxoidum pertussis
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum filamentosum
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
pertactinum
|
8.0 UG | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 1 inactivatus
|
40.0 UI | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 2 inactivatus
|
8.0 UI | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 3 inactivatus
|
32.0 UI | Substance | Wirkstoff (Principe actif) |
|
aluminium
|
0.5 MG | Substance | HNIDK |
|
aluminii hydroxidum hydricum ad adsorptionem
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrium
|
1.8 MG | Substance | HBESI |
|
medium 199
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
neomycini sulfas
|
- | Substance | HNIDK |
|
polymyxini B sulfas
|
- | Substance | HNIDK |
|
formaldehydum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 38.25
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/04/2000
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 638
- Drug name
- Infanrix DTPa-IPV, Injektionssuspension
- Galenic form
- SUPA
- ATC Code
- J07CA02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 20/08/1999
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- INFANRIX DTPa-IPV susp inj (n ser pré) 0.5 ml
- Description (DE)
- INFANRIX DTPa-IPV Inj Susp (n Fertspr) 0.5 ml
- Market launch
- 20/08/1999
- Narcotic (BTM)
- No
Application methods
IMU